Biomarkers and Liquid Biopsy

Biomarkers and Liquid Biopsy focuses on the use of biomarkers for cancer detection, prognosis, and monitoring. This track emphasizes liquid biopsy as a non-invasive method for early cancer detection, offering advantages over traditional tissue biopsies. Liquid biopsy analyzes circulating tumor cells, DNA, RNA, and exosomes in bodily fluids like blood, enabling personalized treatment strategies. By identifying genetic alterations and monitoring tumor dynamics, liquid biopsy aids in tailoring therapies and tracking treatment response, thus improving patient outcomes and reducing the need for invasive procedures.

Related Conference: Cancer Conferences | Cancer Research Conferences | Oncology Conferences | Cancer Science Conferences | Cancer Therapy Conferences | World Cancer Congress | Breast Cancer Conferences | Blood Cancer Conferences | Cancer Stem Cell Conferences | Bone Marrow Conferences | European Cancer Conferences

 

    Related Conference of Biomarkers and Liquid Biopsy

    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    April 07-08, 2025

    15th World Congress on Breast Cancer

    Vancouver, Canada
    April 28-29, 2025

    35th Experts Meet On Cancer Research & Therapy

    Aix-en-Provence, France
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    July 14-15, 2025

    5th World Congress on Breast Cancer

    Berlin, Germany
    July 28-29, 2025

    45th Euro Congress on Cancer Science & Therapy

    Paris, France
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain

    Biomarkers and Liquid Biopsy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in